Corporate News     04-Mar-23
Orchid Pharma and Orchid Bio Pharma signs MoU to obtain license for 7ACA technology
Orchid Pharma and its wholly owned subsidiary, Orchid Bio Pharma have entered into a Memorandum of Understanding (MoU) with an overseas technology provider for in-licensing 7ACA technology.

Orchid Bio Pharma has been granted approval by Competent Authority under the Production Linked Incentive (PLI) Scheme for manufacturing of product “7 ACA”.

Previous News
  Orchid Pharma reports standalone net loss of Rs 54.31 crore in the March 2020 quarter
 ( Results - Announcements 30-Jun-20   12:44 )
  Orchid Pharma consolidated net profit rises 287.75% in the December 2023 quarter
 ( Results - Announcements 08-Feb-24   17:29 )
  Orchid Pharma consolidated net profit declines 29.39% in the December 2024 quarter
 ( Results - Announcements 12-Feb-25   17:53 )
  Orchid Pharma and Orchid Bio Pharma signs MoU to obtain license for 7ACA technology
 ( Corporate News - 04-Mar-23   10:20 )
  Orchid Pharma reports consolidated net loss of Rs 24.42 crore in the September 2020 quarter
 ( Results - Announcements 12-Nov-20   08:34 )
  Orchid Pharma receives DCGI approval for Enmetazobactam
 ( Corporate News - 06-Jun-24   13:06 )
  Orchid Pharma to hold AGM
 ( Corporate News - 07-Dec-20   12:03 )
  Orchid Pharma receives ANDA approval for Risedronate Sodium Tablets
 ( Corporate News - 14-May-19   16:55 )
  Orchid Chemicals & Pharmaceuticals announces change in directorate
 ( Corporate News - 01-Jun-15   19:05 )
  Orchid Pharma to conduct board meeting
 ( Corporate News - 13-Apr-18   11:50 )
  Orchid Pharma reports standalone net loss of Rs 166.28 crore in the June 2016 quarter
 ( Results - Announcements 13-Aug-16   17:40 )
Other Stories
  Divis Laboratories enters into long term manufacturing and supply agreement
  18-Apr-25   10:02
  Tata Chemicals receives affirmation in LT corporate family rating
  17-Apr-25   20:24
  Board of NTPC appoints director
  17-Apr-25   20:17
  SBI Cards announces appointment of nominee director
  17-Apr-25   20:15
  Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
  17-Apr-25   20:08
  Suzlon Energy allots 99,000 equity shares under ESOP
  17-Apr-25   20:05
  UTIAMC allots 10,654 equity shares under ESOS
  17-Apr-25   20:03
  Indian Oil Corporation to announce Quarterly Result
  17-Apr-25   17:17
  Infosys to convene AGM
  17-Apr-25   17:17
  Board of Infosys recommends final dividend
  17-Apr-25   17:12
Back Top